For Pregnancy and Infant Loss Awareness Month, learn how one woman advocated for herself and fought to complete her family after she was diagnosed with hemolyticdisease of the fetus and newborn—and why Johnson & Johnson is committed to finding a better treatment for this rare and deadly blood disorder.

Bethany Weathersby was nine weeks pregnant when she went in for her first ultrasound. At 31 years old, she wasn’t expecting anything out of the ordinary. After all, she’d already given birth to two healthy boys, Liam and Asher, and she and her husband Josh were thrilled that this time they were having a girl.

So she was shocked to discover that the seemingly healthy infant she was carrying was at risk of developing a rare blood disorder known as hemolytic disease of the fetus and newborn (HDFN). In severe cases, the condition can lead to significant complications for the baby and it can even be fatal—so some doctors advise women not to plan future pregnancies if they have had severe HDFN.

Read the full article on Johnson & Johnson’s website